Dose Finding and Beyond in Biopharmaceutical Development
This book covers topics in 2 parts: 1) Review of FDA Guidance, 2) Novel Designs and Analyses. While covering basic principles of dose finding, this book details advancements made in drug development. Finding the right dose(s) is one of the most important objectives in new drug development. In Phase...
שמור ב:
| מחבר תאגידי: | |
|---|---|
| מחברים אחרים: | , , , , |
| פורמט: | אלקטרוני ספר אלקטרוני |
| שפה: | אנגלית |
| יצא לאור: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2025.
|
| מהדורה: | 1st ed. 2025. |
| סדרה: | ICSA Book Series in Statistics,
|
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1007/978-3-031-67110-4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-67110-4 | ||
| 003 | DE-He213 | ||
| 005 | 20260706115554.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 241028s2025 sz | s |||| 0|eng d | ||
| 020 | |a 9783031671104 |9 978-3-031-67110-4 | ||
| 024 | 7 | |a 10.1007/978-3-031-67110-4 |2 doi | |
| 050 | 4 | |a QH323.5 | |
| 072 | 7 | |a PBT |2 bicssc | |
| 072 | 7 | |a MED090000 |2 bisacsh | |
| 072 | 7 | |a PBT |2 thema | |
| 082 | 0 | 4 | |a 570.15195 |2 23 |
| 245 | 1 | 0 | |a Dose Finding and Beyond in Biopharmaceutical Development |h [electronic resource] / |c edited by Jingjing Ye, Ding-Geng Chen, Wen Zhou, Qiqi Deng, Joseph C. Cappelleri. |
| 250 | |a 1st ed. 2025. | ||
| 264 | 1 | |a Cham : |b Springer Nature Switzerland : |b Imprint: Springer, |c 2025. | |
| 300 | |a XVII, 254 p. 43 illus. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a ICSA Book Series in Statistics, |x 2199-0999 | |
| 505 | 0 | |a Emerging Topics in Dose-Finding and Beyond -- Understanding FDA Guidance On Dosage Optimization For Oncology Therapies -- FDA Project Optimus: The "Paradigm-Shifting" Initiative for Oncology Drug Development -- Challenges and Practical Guidance on the Implementation of Novel Oncology Dose Escalation Designs -- Challenges and Practical Guidance on the Implementation of Novel Oncology Dose Escalation Designs -- Monotonic Dose Response Assumption and Curve-Free Designs for Phase I Dose Finding Trials -- Dose Selection with 2-in-1 Design -- A Rank-Based Approach to Improve the Efficiency of Inferential Seamless Phase 2/3 Clinical Trials with Dose Optimization -- Comparing MCP-MOD and Ordinal Linear Contrast Test in Dose Finding Clinical Trials: A Thorough Examination -- Patient-Reported Tolerability in Drug Development -- Endpoint Development and Validation. | |
| 520 | |a This book covers topics in 2 parts: 1) Review of FDA Guidance, 2) Novel Designs and Analyses. While covering basic principles of dose finding, this book details advancements made in drug development. Finding the right dose(s) is one of the most important objectives in new drug development. In Phase I clinical development, one of the objectives is to escalate test doses from low to high. The low doses should be safe, then escalate up to the maximally tolerable dose (MTD). Phase Ⅱ clinical trials then lower test doses to the minimal efficacious dose (MinED). Dose range of a study drug can be thought of as the doses between MinED and MTD. From this dose range, one or a few doses are selected for Phase Ⅲ confirmation. In practice, dose finding is a very difficult in every phase of clinical development for new drugs. The editors brought distinguished researchers and practitioners in biopharmaceuticals and universities, to discuss the statistical procedures, useful methods, and their novel applications in dose finding. The chapters in the book present emerging topics in dose-finding and related interdisciplinary areas. This timely book is a valuable resource to stimulate the development of this growing and exciting field in drug development. . | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 650 | 0 | |a Biometry. | |
| 650 | 0 | |a Experimental design. | |
| 650 | 0 | |a Data mining. | |
| 650 | 1 | 4 | |a Biostatistics. |
| 650 | 2 | 4 | |a Design of Experiments. |
| 650 | 2 | 4 | |a Data Mining and Knowledge Discovery. |
| 700 | 1 | |a Ye, Jingjing. |e editor. |0 (orcid)0000-0003-0086-2228 |1 https://orcid.org/0000-0003-0086-2228 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Chen, Ding-Geng. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Zhou, Wen. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Deng, Qiqi. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Cappelleri, Joseph C. |e editor. |0 (orcid)0000-0001-9586-0748 |1 https://orcid.org/0000-0001-9586-0748 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031671098 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031671111 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031671128 |
| 830 | 0 | |a ICSA Book Series in Statistics, |x 2199-0999 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-67110-4 |
| 912 | |a ZDB-2-SMA | ||
| 912 | |a ZDB-2-SXMS | ||
| 912 | |a ZDB-2-251 | ||
| 950 | |a Mathematics and Statistics (SpringerNature-11649) | ||
| 950 | |a Mathematics and Statistics (R0) (SpringerNature-43713) | ||
| 950 | |a Focus Bundle Mathematics and Statistics (SpringerNature-85421) | ||